Delivery Order SPE2DE24D0021-SPE2D625F2NAY
- Not listed
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,425.78 on August 13, 2025, for the procurement of vaginal negative control specimens (6 x 0.9 milliliter each). This fixed-price contract with economic price adjustment will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of August 20, 2025. The award was made without a set-aside designation, reflecting Fisher Scientific's competitive standing in open federal procurement. The funding agency is...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,376.30 for vaginal negative control samples (6 x 0.9 mL per unit) on August 11, 2025, with an ultimate completion date of August 18, 2025. The contract employs a fixed-price pricing structure with economic price adjustment provisions and will be performed in Pittsburgh, Pennsylvania. This delivery order is issued under a larger contract vehicle and represents a pediatric purchase without set-aside designation,...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,883.44 for vaginal positive control specimens (6 units × 0.9 milliliters each) by the Department of Defense's Medical Supply Chain division. This fixed-price contract with economic price adjustment authority is set for completion by September 17, 2025, and will be performed in Pittsburgh, Pennsylvania. As a child contract under a larger vehicle, this delivery order represents a routine procurement of specialized...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,540.15 for vaginal positive control material (6 units of 0.9 milliliters each) by the Medical Supply Chain, a defense-focused federal agency. The contract, awarded on September 15, 2025, is structured as a fixed-price delivery order with economic price adjustment provisions and is scheduled for ultimate completion by September 22, 2025. The award represents an open competition procurement with no set-aside...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,953.78 by the Defense Medical Supply Chain on August 14, 2025, for the supply of vaginal positive control material in 6x0.9ml units. The contract, which employs fixed-price pricing with economic price adjustment terms, carries a completion date of August 21, 2025, and will be performed in Pittsburgh, Pennsylvania. This award represents a child contract under a larger vehicle and was made through open competition with no...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $3,394.40 by the Department of Defense's Medical Supply Chain for the provision of vaginal positive control solutions (6 x 0.9 mL per unit). The contract, awarded on September 11, 2025, carries a fixed-price structure with economic price adjustment provisions and is scheduled for ultimate completion by September 18, 2025. Performance will take place in Pittsburgh, Pennsylvania. This delivery order represents a child...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $4,154.16 by the Department of Defense's Medical Supply Chain on August 6, 2025, for the procurement of vaginal positive control material (6 units at 0.9 milliliters each). This fixed-price delivery order with economic price adjustment authority is scheduled for ultimate completion by August 13, 2025, with performance to be fulfilled in Pittsburgh, Pennsylvania. The contract was awarded through open competition with no...
- Fisher Scientific Company L.L.C. was awarded a delivery order on September 9, 2025, valued at $2,772.01 for the procurement of vaginal positive control solutions (6x0.9ml per unit) from the Defense Medical Supply Chain. This is a fixed price contract with economic price adjustment provisions, with a completion date of September 16, 2025. The contract was awarded without a set-aside designation through open competition, and will be fulfilled at Fisher Scientific's Pittsburgh, Pennsylvania...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,491.98 on August 6, 2025, for the supply of vaginal positive control material (6 units at 0.9 milliliters each). This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 13, 2025, and will be performed in Pittsburgh, Pennsylvania. The contract was awarded by the Defense Medical Supply Chain, a defense-focused federal agency supporting military and related healthcare...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,038.54 by the Defense Medical Supply Chain on September 11, 2025, for the procurement of vaginal positive control solutions (6 units at 0.9 milliliters each). This fixed-price contract with economic price adjustment provisions is scheduled for completion by September 18, 2025, and will be performed in Pittsburgh, Pennsylvania. The award represents a child contract under a larger vehicle, with no small business set-aside...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F2NAYDelivery Order
Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,112.82 on September 4, 2025, for the supply of vaginal negative control specimens (6 units at 0.9 milliliters each) to support federal medical supply chain operations. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and does not utilize a set-aside designation, indicating open competition. The place of performance is Pittsburgh, Pennsylvania, with an ultimate completion date of September 11, 2025. As a child contract under a larger vehicle, this award leverages Fisher Scientific's established capabilities as a major supplier of laboratory and medical supplies to federal agencies, including the Department of Veterans Affairs and National Institutes of Health. This delivery order supports the Medical Supply Chain within the Department of Defense's health infrastructure. Fisher Scientific, registered as a federal contractor since July 2001, regularly provides specialized laboratory and medical testing solutions across multiple government agencies. The negative control specimens are critical quality assurance components used in laboratory diagnostic and testing protocols to validate test accuracy and reliability. The abbreviated timeline and modest ceiling value reflect the routine nature of this supply requisition within the broader federal medical procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/4/25 |